{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:08:25Z","timestamp":1791230905155,"version":"4.1.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2022IL0011"],"award-info":[{"award-number":["2022IL0011"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"the National Research Foundation","doi-asserted-by":"crossref","award":["NRF-2020R1F1A1048577"],"award-info":[{"award-number":["NRF-2020R1F1A1048577"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s12035-022-03017-9","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T20:21:42Z","timestamp":1662236502000},"page":"6956-6970","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pyruvate Prevents Dopaminergic Neurodegeneration and Motor Deficits in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"59","author":[{"given":"Yun-Mi","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Yeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4699-9596","authenticated-orcid":false,"given":"Onyou","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3041-0145","authenticated-orcid":false,"given":"Joo-Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,3]]},"reference":[{"key":"3017_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1749-6632.2003.tb07470.x","volume":"991","author":"MF Beal","year":"2003","unstructured":"Beal MF (2003) Mitochondria, oxidative damage, and inflammation in Parkinson\u2019s disease. Ann N Y Acad Sci 991:120\u2013131. https:\/\/doi.org\/10.1111\/j.1749-6632.2003.tb07470.x","journal-title":"Ann N Y Acad Sci"},{"key":"3017_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909. https:\/\/doi.org\/10.1016\/s0896-6273(03)00568-3","journal-title":"Neuron"},{"key":"3017_CR3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","volume":"991","author":"EC Hirsch","year":"2003","unstructured":"Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP (2003) The role of glial reaction and inflammation in Parkinson\u2019s disease. Ann N Y Acad Sci 991:214\u2013228. https:\/\/doi.org\/10.1111\/j.1749-6632.2003.tb07478.x","journal-title":"Ann N Y Acad Sci"},{"key":"3017_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1749-6632.1999.tb07824.x","volume":"893","author":"MP Mattson","year":"1999","unstructured":"Mattson MP, Pedersen WA, Duan W, Culmsee C, Camandola S (1999) Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer\u2019s and Parkinson\u2019s diseases. Ann N Y Acad Sci 893:154\u2013175. https:\/\/doi.org\/10.1111\/j.1749-6632.1999.tb07824.x","journal-title":"Ann N Y Acad Sci"},{"key":"3017_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fnagi.2018.00301","volume":"10","author":"JW Blaszczyk","year":"2018","unstructured":"Blaszczyk JW (2018) The emerging role of energy metabolism and neuroprotective strategies in Parkinson\u2019s disease. Front Aging Neurosci 10:301. https:\/\/doi.org\/10.3389\/fnagi.2018.00301","journal-title":"Front Aging Neurosci"},{"key":"3017_CR6","first-page":"600","volume":"60","author":"LS Forno","year":"1993","unstructured":"Forno LS, DeLanney LE, Irwin I, Langston JW (1993) Similarities and differences between MPTP-induced parkinsonsim and Parkinson\u2019s disease. Neuropathologic considerations. Adv Neurol 60:600\u2013608","journal-title":"Adv Neurol"},{"key":"3017_CR7","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease. J Neurochem 52:1830\u20131836. https:\/\/doi.org\/10.1111\/j.1471-4159.1989.tb07264.x","journal-title":"J Neurochem"},{"key":"3017_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1600-0404.1993.tb00013.x","volume":"146","author":"P Jenner","year":"1993","unstructured":"Jenner P (1993) Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson\u2019s disease. Acta Neurol Scand Suppl 146:6\u201313","journal-title":"Acta Neurol Scand Suppl"},{"key":"3017_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","volume":"52","author":"P Riederer","year":"1989","unstructured":"Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MB (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52:515\u2013520. https:\/\/doi.org\/10.1111\/j.1471-4159.1989.tb09150.x","journal-title":"J Neurochem"},{"key":"3017_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0304-3940(86)90320-4","volume":"67","author":"TL Perry","year":"1986","unstructured":"Perry TL, Yong VW (1986) Idiopathic Parkinson\u2019s disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett 67:269\u2013274. https:\/\/doi.org\/10.1016\/0304-3940(86)90320-4","journal-title":"Neurosci Lett"},{"key":"3017_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0304-3940(92)90355-b","volume":"142","author":"E Sofic","year":"1992","unstructured":"Sofic E, Lange KW, Jellinger K, Riederer P (1992) Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson\u2019s disease. Neurosci Lett 142:128\u2013130. https:\/\/doi.org\/10.1016\/0304-3940(92)90355-b","journal-title":"Neurosci Lett"},{"key":"3017_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2013.01.003","volume":"62","author":"LH Sanders","year":"2013","unstructured":"Sanders LH, Greenamyre JT (2013) Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radic Biol Med 62:111\u2013120. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.01.003","journal-title":"Free Radic Biol Med"},{"issue":"Suppl 1","key":"3017_CR13","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","volume":"10","author":"PL McGeer","year":"2004","unstructured":"McGeer PL, McGeer EG (2004) Inflammation and neurodegeneration in Parkinson\u2019s disease. Parkinsonism Relat Disord 10 (Suppl 1):S3-7. https:\/\/doi.org\/10.1016\/j.parkreldis.2004.01.005","journal-title":"Parkinsonism Relat Disord"},{"key":"3017_CR14","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/mds.21751","volume":"23","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG (2008) Glial reactions in Parkinson\u2019s disease. Mov Disord 23:474\u2013483. https:\/\/doi.org\/10.1002\/mds.21751","journal-title":"Mov Disord"},{"key":"3017_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/JPD-2011-11023","volume":"1","author":"GE Meredith","year":"2011","unstructured":"Meredith GE, Rademacher DJ (2011) MPTP mouse models of Parkinson\u2019s disease: an update. J Parkinsons Dis 1:19\u201333. https:\/\/doi.org\/10.3233\/JPD-2011-11023","journal-title":"J Parkinsons Dis"},{"key":"3017_CR16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.272.5264.1013","volume":"272","author":"JY Koh","year":"1996","unstructured":"Koh JY, Suh SW, Gwag BJ, He YY, Hsu CY, Choi DW (1996) The role of zinc in selective neuronal death after transient global cerebral ischemia. Science 272:1013\u20131016. https:\/\/doi.org\/10.1126\/science.272.5264.1013","journal-title":"Science"},{"key":"3017_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0006-8993(98)00943-3","volume":"812","author":"JC Sorensen","year":"1998","unstructured":"Sorensen JC, Mattsson B, Andreasen A, Johansson BB (1998) Rapid disappearance of zinc positive terminals in focal brain ischemia. Brain Res 812:265\u2013269. https:\/\/doi.org\/10.1016\/s0006-8993(98)00943-3","journal-title":"Brain Res"},{"key":"3017_CR18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/s0306-4522(02)00513-4","volume":"115","author":"JM Lee","year":"2002","unstructured":"Lee JM, Zipfel GJ, Park KH, He YY, Hsu CY, Choi DW (2002) Zinc translocation accelerates infarction after mild transient focal ischemia. Neuroscience 115:871\u2013878. https:\/\/doi.org\/10.1016\/s0306-4522(02)00513-4","journal-title":"Neuroscience"},{"key":"3017_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0006-8993(88)90899-2","volume":"446","author":"CJ Frederickson","year":"1988","unstructured":"Frederickson CJ, Hernandez MD, Goik SA, Morton JD, McGinty JF (1988) Loss of zinc staining from hippocampal mossy fibers during kainic acid induced seizures: a histofluorescence study. Brain Res 446:383\u2013386. https:\/\/doi.org\/10.1016\/0006-8993(88)90899-2","journal-title":"Brain Res"},{"key":"3017_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0006-8993(89)90199-6","volume":"480","author":"CJ Frederickson","year":"1989","unstructured":"Frederickson CJ, Hernandez MD, McGinty JF (1989) Translocation of zinc may contribute to seizure-induced death of neurons. Brain Res 480:317\u2013321. https:\/\/doi.org\/10.1016\/0006-8993(89)90199-6","journal-title":"Brain Res"},{"key":"3017_CR21","doi-asserted-by":"publisher","first-page":"RC79","DOI":"10.1523\/JNEUROSCI.20-11-j0003.2000","volume":"20","author":"JY Lee","year":"2000","unstructured":"Lee JY, Cole TB, Palmiter RD, Koh JY (2000) Accumulation of zinc in degenerating hippocampal neurons of ZnT3-null mice after seizures: evidence against synaptic vesicle origin. J Neurosci 20:RC79. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-11-j0003.2000","journal-title":"J Neurosci"},{"key":"3017_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/s0006-8993(99)02095-8","volume":"85","author":"SW Suh","year":"2000","unstructured":"Suh SW, Chen JW, Motamedi M, Bell B, Listiak K, Pons NF, Danscher G, Frederickson CJ (2000) Evidence that synaptically-released zinc contributes to neuronal injury after traumatic brain injury. Brain Res 85:268\u2013273. https:\/\/doi.org\/10.1016\/s0006-8993(99)02095-8","journal-title":"Brain Res"},{"key":"3017_CR23","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.nbd.2004.04.017","volume":"16","author":"SW Suh","year":"2004","unstructured":"Suh SW, Garnier P, Aoyama K, Chen Y, Swanson RA (2004) Zinc release contributes to hypoglycemia-induced neuronal death. Neurobiol Dis 16:538\u2013545. https:\/\/doi.org\/10.1016\/j.nbd.2004.04.017","journal-title":"Neurobiol Dis"},{"key":"3017_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0304-3940(90)90002-q","volume":"109","author":"N Tonder","year":"1990","unstructured":"Tonder N, Johansen FF, Frederickson CJ, Zimmer J, Diemer NH (1990) Possible role of zinc in the selective degeneration of dentate hilar neurons after cerebral ischemia in the adult rat. Neurosci Lett 109:247\u2013252. https:\/\/doi.org\/10.1016\/0304-3940(90)90002-q","journal-title":"Neurosci Lett"},{"key":"3017_CR25","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1046\/j.1471-4159.2000.0751878.x","volume":"75","author":"E Aizenman","year":"2000","unstructured":"Aizenman E, Stout AK, Hartnett KA, Dineley KE, McLaughlin B, Reynolds IJ (2000) Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J Neurochem 75:1878\u20131888. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0751878.x","journal-title":"J Neurochem"},{"key":"3017_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/s0014-4886(03)00382-0","volume":"184","author":"JY Lee","year":"2003","unstructured":"Lee JY, Kim JH, Palmiter RD, Koh JY (2003) Zinc released from metallothionein-III may contribute to hippocampal CA1 and thalamic neuronal death following acute brain injury. Exp Neurol 184:337\u2013347. https:\/\/doi.org\/10.1016\/s0014-4886(03)00382-0","journal-title":"Exp Neurol"},{"key":"3017_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0304-3940(00)01120-4","volume":"286","author":"J Chung","year":"2000","unstructured":"Chung J, Chang S, Kim Y, Shin H (2000) Zinc increases the excitability of dopaminergic neurons in rat substantia nigra. Neurosci Lett 286:183\u2013186. https:\/\/doi.org\/10.1016\/s0304-3940(00)01120-4","journal-title":"Neurosci Lett"},{"key":"3017_CR28","doi-asserted-by":"publisher","first-page":"578","DOI":"10.5607\/en.2019.28.5.578","volume":"28","author":"J Noh","year":"2019","unstructured":"Noh J, Chung JM (2019) Modulation of dopaminergic neuronal excitability by zinc through the regulation of calcium-related channels. Exp Neurobiol 28:578\u2013592. https:\/\/doi.org\/10.5607\/en.2019.28.5.578","journal-title":"Exp Neurobiol"},{"issue":"Pt 4","key":"3017_CR29","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","volume":"114","author":"DT Dexter","year":"1991","unstructured":"Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P et al (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(Pt 4):1953\u20131975. https:\/\/doi.org\/10.1093\/brain\/114.4.1953","journal-title":"Brain"},{"key":"3017_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12035-018-1075-z","volume":"56","author":"H Tamano","year":"2019","unstructured":"Tamano H, Nishio R, Morioka H, Takeda A (2019) Extracellular Zn(2+) influx into nigral dopaminergic neurons plays a key role for pathogenesis of 6-hydroxydopamine-induced Parkinson\u2019s disease in rats. Mol Neurobiol 56:435\u2013443. https:\/\/doi.org\/10.1007\/s12035-018-1075-z","journal-title":"Mol Neurobiol"},{"key":"3017_CR31","doi-asserted-by":"publisher","first-page":"104681","DOI":"10.1016\/j.nbd.2019.104681","volume":"134","author":"J Sikora","year":"2020","unstructured":"Sikora J, Kieffer BL, Paoletti P, Ouagazzal AM (2020) Synaptic zinc contributes to motor and cognitive deficits in 6-hydroxydopamine mouse models of Parkinson\u2019s disease. Neurobiol Dis 134:104681. https:\/\/doi.org\/10.1016\/j.nbd.2019.104681","journal-title":"Neurobiol Dis"},{"key":"3017_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.brainres.2009.06.046","volume":"1286","author":"JY Lee","year":"2009","unstructured":"Lee JY, Son HJ, Choi JH, Cho E, Kim J, Chung SJ, Hwang O, Koh JY (2009) Cytosolic labile zinc accumulation in degenerating dopaminergic neurons of mouse brain after MPTP treatment. Brain Res 1286:208\u2013214. https:\/\/doi.org\/10.1016\/j.brainres.2009.06.046","journal-title":"Brain Res"},{"key":"3017_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0014-2999(86)90444-9","volume":"129","author":"PK Sonsalla","year":"1986","unstructured":"Sonsalla PK, Heikkila RE (1986) The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice. Eur J Pharmacol 129:339\u2013345. https:\/\/doi.org\/10.1016\/0014-2999(86)90444-9","journal-title":"Eur J Pharmacol"},{"key":"3017_CR34","doi-asserted-by":"publisher","first-page":"9060","DOI":"10.1523\/JNEUROSCI.17-23-09060.1997","volume":"17","author":"S Desagher","year":"1997","unstructured":"Desagher S, Glowinski J, Premont J (1997) Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci 17:9060\u20139067. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-23-09060.1997","journal-title":"J Neurosci"},{"key":"3017_CR35","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1523\/JNEUROSCI.21-10-03322.2001","volume":"21","author":"XF Wang","year":"2001","unstructured":"Wang XF, Cynader MS (2001) Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity. J Neurosci 21:3322\u20133331. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-10-03322.2001","journal-title":"J Neurosci"},{"key":"3017_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3892\/ijmm.2015.2431","volume":"37","author":"B Relja","year":"2016","unstructured":"Relja B, Omid N, Wagner N, Mors K, Werner I, Juengel E, Perl M, Marzi I (2016) Ethanol, ethyl and sodium pyruvate decrease the inflammatory responses of human lung epithelial cells via Akt and NF-\u03baB in vitro but have a low impact on hepatocellular cells. Int J Mol Med 37:517\u2013525. https:\/\/doi.org\/10.3892\/ijmm.2015.2431","journal-title":"Int J Mol Med"},{"key":"3017_CR37","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1523\/JNEUROSCI.20-09-03139.2000","volume":"20","author":"CT Sheline","year":"2000","unstructured":"Sheline CT, Behrens MM, Choi DW (2000) Zinc-induced cortical neuronal death: contribution of energy failure attributable to loss of NAD(+) and inhibition of glycolysis. J Neurosci 20:3139\u20133146. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-09-03139.2000","journal-title":"J Neurosci"},{"key":"3017_CR38","doi-asserted-by":"publisher","first-page":"RC171","DOI":"10.1523\/JNEUROSCI.21-20-j0002.2001","volume":"21","author":"JY Lee","year":"2001","unstructured":"Lee JY, Kim YH, Koh JY (2001) Protection by pyruvate against transient forebrain ischemia in rats. J Neurosci 21:RC171. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-20-j0002.2001","journal-title":"J Neurosci"},{"key":"3017_CR39","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1046\/j.1460-9568.1999.00745.x","volume":"11","author":"M Maus","year":"1999","unstructured":"Maus M, Marin P, Israel M, Glowinski J, Premont J (1999) Pyruvate and lactate protect striatal neurons against N-methyl-D-aspartate-induced neurotoxicity. Eur J Neurosci 11:3215\u20133224. https:\/\/doi.org\/10.1046\/j.1460-9568.1999.00745.x","journal-title":"Eur J Neurosci"},{"key":"3017_CR40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.nbd.2006.12.007","volume":"26","author":"JS Yi","year":"2007","unstructured":"Yi JS, Kim TY, Kyu Kim D, Koh JY (2007) Systemic pyruvate administration markedly reduces infarcts and motor deficits in rat models of transient and permanent focal cerebral ischemia. Neurobiol Dis 26:94\u2013104. https:\/\/doi.org\/10.1016\/j.nbd.2006.12.007","journal-title":"Neurobiol Dis"},{"key":"3017_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.nbd.2009.07.018","volume":"36","author":"Q Wang","year":"2009","unstructured":"Wang Q, van Hoecke M, Tang XN, Lee H, Zheng Z, Swanson RA, Yenari MA (2009) Pyruvate protects against experimental stroke via an anti-inflammatory mechanism. Neurobiol Dis 36:223\u2013231. https:\/\/doi.org\/10.1016\/j.nbd.2009.07.018","journal-title":"Neurobiol Dis"},{"key":"3017_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.expneurol.2007.08.013","volume":"208","author":"TY Kim","year":"2007","unstructured":"Kim TY, Yi JS, Chung SJ, Kim DK, Byun HR, Lee JY, Koh JY (2007) Pyruvate protects against kainate-induced epileptic brain damage in rats. Exp Neurol 208:159\u2013167. https:\/\/doi.org\/10.1016\/j.expneurol.2007.08.013","journal-title":"Exp Neurol"},{"key":"3017_CR43","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1089\/neu.2008.0771","volume":"26","author":"M Fukushima","year":"2009","unstructured":"Fukushima M, Lee SM, Moro N, Hovda DA, Sutton RL (2009) Metabolic and histologic effects of sodium pyruvate treatment in the rat after cortical contusion injury. J Neurotrauma 26:1095\u20131110. https:\/\/doi.org\/10.1089\/neu.2008.0771","journal-title":"J Neurotrauma"},{"key":"3017_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.expneurol.2010.07.013","volume":"225","author":"N Moro","year":"2010","unstructured":"Moro N, Sutton RL (2010) Beneficial effects of sodium or ethyl pyruvate after traumatic brain injury in the rat. Exp Neurol 225:391\u2013401. https:\/\/doi.org\/10.1016\/j.expneurol.2010.07.013","journal-title":"Exp Neurol"},{"key":"3017_CR45","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.2337\/diabetes.54.5.1452","volume":"54","author":"SW Suh","year":"2005","unstructured":"Suh SW, Aoyama K, Matsumori Y, Liu J, Swanson RA (2005) Pyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment. Diabetes 54:1452\u20131458. https:\/\/doi.org\/10.2337\/diabetes.54.5.1452","journal-title":"Diabetes"},{"key":"3017_CR46","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1084\/jem.165.2.500","volume":"165","author":"J O'Donnell-Tormey","year":"1987","unstructured":"O\u2019Donnell-Tormey J, Nathan CF, Lanks K, DeBoer CJ, de la Harpe J (1987) Secretion of pyruvate. An antioxidant defense of mammalian cells. J Exp Med 165:500\u2013514. https:\/\/doi.org\/10.1084\/jem.165.2.500","journal-title":"J Exp Med"},{"key":"3017_CR47","first-page":"RA79","volume":"12","author":"UN Das","year":"2006","unstructured":"Das UN (2006) Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule. Med Sci Monit 12:RA79-84","journal-title":"Med Sci Monit"},{"key":"3017_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fnins.2015.00017","volume":"9","author":"Y Zilberter","year":"2015","unstructured":"Zilberter Y, Gubkina O, Ivanov AI (2015) A unique array of neuroprotective effects of pyruvate in neuropathology. Front Neurosci 9:17. https:\/\/doi.org\/10.3389\/fnins.2015.00017","journal-title":"Front Neurosci"},{"key":"3017_CR49","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ajem.2015.12.040","volume":"34","author":"R Liu","year":"2016","unstructured":"Liu R, Wang SM, Liu XQ, Guo SJ, Wang HB, Hu S, Zhou FQ, Sheng ZY (2016) Pyruvate alleviates lipid peroxidation and multiple-organ dysfunction in rats with hemorrhagic shock. Am J Emerg Med 34:525\u2013530. https:\/\/doi.org\/10.1016\/j.ajem.2015.12.040","journal-title":"Am J Emerg Med"},{"key":"3017_CR50","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s10753-018-0917-1","volume":"42","author":"K Effenberger-Neidnicht","year":"2019","unstructured":"Effenberger-Neidnicht K, Brauckmann S, Jagers J, Patyk V, Waack IN, Kirsch M (2019) Protective effects of sodium pyruvate during systemic inflammation limited to the correction of metabolic acidosis. Inflammation 42:598\u2013605. https:\/\/doi.org\/10.1007\/s10753-018-0917-1","journal-title":"Inflammation"},{"key":"3017_CR51","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.jcbfm.9600335","volume":"27","author":"J Zeng","year":"2007","unstructured":"Zeng J, Yang GY, Ying W, Kelly M, Hirai K, James TL, Swanson RA, Litt L (2007) Pyruvate improves recovery after PARP-1-associated energy failure induced by oxidative stress in neonatal rat cerebrocortical slices. J Cereb Blood Flow Metab 27:304\u2013315. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600335","journal-title":"J Cereb Blood Flow Metab"},{"key":"3017_CR52","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.neuropharm.2016.02.001","volume":"105","author":"SW Kim","year":"2016","unstructured":"Kim SW, Lee HK, Kim HJ, Yoon SH, Lee JK (2016) Neuroprotective effect of ethyl pyruvate against Zn(2+) toxicity via NAD replenishment and direct Zn(2+) chelation. Neuropharmacology 105:411\u2013419. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.001","journal-title":"Neuropharmacology"},{"key":"3017_CR53","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1007\/s11033-010-9998-0","volume":"38","author":"Y Miao","year":"2011","unstructured":"Miao Y, Qiu Y, Lin Y, Miao Z, Zhang J, Lu X (2011) Protection by pyruvate against glutamate neurotoxicity is mediated by astrocytes through a glutathione-dependent mechanism. Mol Biol Rep 38:3235\u20133242. https:\/\/doi.org\/10.1007\/s11033-010-9998-0","journal-title":"Mol Biol Rep"},{"key":"3017_CR54","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/jnr.10648","volume":"73","author":"G Alvarez","year":"2003","unstructured":"Alvarez G, Ramos M, Ruiz F, Satrustegui J, Bogonez E (2003) Pyruvate protection against \u03b2-amyloid-induced neuronal death: role of mitochondrial redox state. J Neurosci Res 73:260\u2013269. https:\/\/doi.org\/10.1002\/jnr.10648","journal-title":"J Neurosci Res"},{"key":"3017_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.11.032","volume":"1132","author":"X Wang","year":"2007","unstructured":"Wang X, Perez E, Liu R, Yan LJ, Mallet RT, Yang SH (2007) Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells. Brain Res 1132:1\u20139. https:\/\/doi.org\/10.1016\/j.brainres.2006.11.032","journal-title":"Brain Res"},{"key":"3017_CR56","doi-asserted-by":"publisher","first-page":"983","DOI":"10.14336\/AD.2020.1015","volume":"12","author":"PS Ariyannur","year":"2021","unstructured":"Ariyannur PS, Xing G, Barry ES, Benford B, Grunberg NE, Sharma P (2021) Effects of pyruvate administration on mitochondrial enzymes, neurological behaviors, and neurodegeneration after traumatic brain injury. Aging Dis 12:983\u2013999. https:\/\/doi.org\/10.14336\/AD.2020.1015","journal-title":"Aging Dis"},{"key":"3017_CR57","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.nbd.2014.11.013","volume":"81","author":"E Isopi","year":"2015","unstructured":"Isopi E, Granzotto A, Corona C, Bomba M, Ciavardelli D et al (2015) Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer\u2019s disease without reducing amyloid and tau pathology. Neurobiol Dis 81:214\u2013224. https:\/\/doi.org\/10.1016\/j.nbd.2014.11.013","journal-title":"Neurobiol Dis"},{"key":"3017_CR58","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.expneurol.2015.06.008","volume":"271","author":"X Wang","year":"2015","unstructured":"Wang X, Hu X, Yang Y, Takata T, Sakurai T (2015) Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer\u2019s disease. Exp Neurol 271:145\u2013154. https:\/\/doi.org\/10.1016\/j.expneurol.2015.06.008","journal-title":"Exp Neurol"},{"key":"3017_CR59","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/s0014-4886(03)00214-0","volume":"183","author":"JK Ryu","year":"2003","unstructured":"Ryu JK, Kim SU, McLarnon JG (2003) Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington\u2019s disease. Exp Neurol 183:700\u2013704. https:\/\/doi.org\/10.1016\/s0014-4886(03)00214-0","journal-title":"Exp Neurol"},{"key":"3017_CR60","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0304-3940(02)01327-7","volume":"337","author":"E Mazzio","year":"2003","unstructured":"Mazzio E, Soliman KF (2003) Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro. Neurosci Lett 337:77\u201380. https:\/\/doi.org\/10.1016\/s0304-3940(02)01327-7","journal-title":"Neurosci Lett"},{"key":"3017_CR61","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000336558","volume":"11","author":"CT Sheline","year":"2013","unstructured":"Sheline CT, Zhu J, Zhang W, Shi C, Cai AL (2013) Mitochondrial inhibitor models of Huntington\u2019s disease and Parkinson\u2019s disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo. Neurodegener Dis 11:49\u201358. https:\/\/doi.org\/10.1159\/000336558","journal-title":"Neurodegener Dis"},{"key":"3017_CR62","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12035-021-02583-8","volume":"59","author":"EI Fedotova","year":"2022","unstructured":"Fedotova EI, Dolgacheva LP, Abramov AY, Berezhnov AV (2022) Lactate and pyruvate activate autophagy and mitophagy that protect cells in toxic model of Parkinson\u2019s disease. Mol Neurobiol 59:177\u2013190. https:\/\/doi.org\/10.1007\/s12035-021-02583-8","journal-title":"Mol Neurobiol"},{"key":"3017_CR63","first-page":"233","volume":"1","author":"OA Meyer","year":"1979","unstructured":"Meyer OA, Tilson HA, Byrd WC, Riley MT (1979) A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol 1:233\u2013236","journal-title":"Neurobehav Toxicol"},{"key":"3017_CR64","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.brainres.2011.11.007","volume":"1431","author":"JY Lee","year":"2012","unstructured":"Lee JY, Cho E, Ko YE, Kim I, Lee KJ, Kwon SU, Kang DW, Kim JS (2012) Ibudilast, a phosphodiesterase inhibitor with anti-inflammatory activity, protects against ischemic brain injury in rats. Brain Res 1431:97\u2013106. https:\/\/doi.org\/10.1016\/j.brainres.2011.11.007","journal-title":"Brain Res"},{"key":"3017_CR65","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jps.3030460322","volume":"46","author":"NW Dunham","year":"1957","unstructured":"Dunham NW, Miya TS (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc 46:208\u2013209. https:\/\/doi.org\/10.1002\/jps.3030460322","journal-title":"J Am Pharm Assoc Am Pharm Assoc"},{"key":"3017_CR66","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/bpa.12660","volume":"29","author":"SB Oh","year":"2019","unstructured":"Oh SB, Kim MS, Park S, Son H, Kim SY, Kim MS, Jo DG, Tak E et al (2019) Clusterin contributes to early stage of Alzheimer\u2019s disease pathogenesis. Brain Pathol 29:217\u2013231. https:\/\/doi.org\/10.1111\/bpa.12660","journal-title":"Brain Pathol"},{"key":"3017_CR67","doi-asserted-by":"publisher","first-page":"113387","DOI":"10.1016\/j.expneurol.2020.113387","volume":"332","author":"JA Lee","year":"2020","unstructured":"Lee JA, Kim HR, Son HJ, Shin N, Han SH, Cheong CS, Kim DJ, Hwang O (2020) A novel pyrazolo [3,4-d] pyrimidine, KKC080106, activates the Nrf2 pathway and protects nigral dopaminergic neurons. Exp Neurol 332:113387. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113387","journal-title":"Exp Neurol"},{"key":"3017_CR68","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/bph.12973","volume":"172","author":"JA Lee","year":"2015","unstructured":"Lee JA, Kim JH, Woo SY, Son HJ, Han SH, Jang BK, Choi JW, Kim DJ et al (2015) A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson\u2019s disease animal model. Br J Pharmacol 172:1087\u20131100. https:\/\/doi.org\/10.1111\/bph.12973","journal-title":"Br J Pharmacol"},{"key":"3017_CR69","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1111\/j.1476-5381.2011.01692.x","volume":"165","author":"HJ Son","year":"2012","unstructured":"Son HJ, Lee JA, Shin N, Choi JH, Seo JW, Chi DY, Lee CS, Kim EM et al (2012) A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson\u2019s disease induced by MPTP. Br J Pharmacol 165:2213\u20132227. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01692.x","journal-title":"Br J Pharmacol"},{"key":"3017_CR70","doi-asserted-by":"publisher","first-page":"113062","DOI":"10.1016\/j.expneurol.2019.113062","volume":"323","author":"S Stayte","year":"2020","unstructured":"Stayte S, Laloli KJ, Rentsch P, Lowth A, Li KM, Pickford R, Vissel B (2020) The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain. Exp Neurol 323:113062. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113062","journal-title":"Exp Neurol"},{"key":"3017_CR71","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuroscience.2018.04.008","volume":"380","author":"KC Biju","year":"2018","unstructured":"Biju KC, Evans RC, Shrestha K, Carlisle DCB, Gelfond J, Clark RA (2018) Methylene blue ameliorates olfactory dysfunction and motor deficits in a chronic MPTP\/probenecid mouse model of Parkinson\u2019s disease. Neuroscience 380:111\u2013122. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.04.008","journal-title":"Neuroscience"},{"key":"3017_CR72","doi-asserted-by":"publisher","first-page":"577806","DOI":"10.1016\/j.jneuroim.2022.577806","volume":"364","author":"Q Miao","year":"2022","unstructured":"Miao Q, Chai Z, Song LJ, Wang Q, Song GB, Wang J, Yu JZ, Xiao BG et al (2022) The neuroprotective effects and transdifferentiation of astrocytes into dopaminergic neurons of Ginkgolide K on Parkinson\u2019 disease mice. J Neuroimmunol 364:577806. https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577806","journal-title":"J Neuroimmunol"},{"key":"3017_CR73","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1006\/exnr.2002.7990","volume":"177","author":"YH Kim","year":"2002","unstructured":"Kim YH, Koh JY (2002) The role of NADPH oxidase and neuronal nitric oxide synthase in zinc-induced poly(ADP-ribose) polymerase activation and cell death in cortical culture. Exp Neurol 177:407\u2013418. https:\/\/doi.org\/10.1006\/exnr.2002.7990","journal-title":"Exp Neurol"},{"key":"3017_CR74","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/s0006-8993(98)00829-4","volume":"80","author":"C Cosi","year":"1998","unstructured":"Cosi C, Marien M (1998) Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide. Brain Res 80:58\u201367. https:\/\/doi.org\/10.1016\/s0006-8993(98)00829-4","journal-title":"Brain Res"},{"key":"3017_CR75","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1073\/pnas.96.10.5774","volume":"96","author":"AS Mandir","year":"1999","unstructured":"Mandir AS, Przedborski S, Jackson-Lewis V, Wang ZQ, Simbulan-Rosenthal CM et al (1999) Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci USA 96:5774\u20135779. https:\/\/doi.org\/10.1073\/pnas.96.10.5774","journal-title":"Proc Natl Acad Sci USA"},{"key":"3017_CR76","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.athoracsur.2010.06.010","volume":"90","author":"MG Ryou","year":"2010","unstructured":"Ryou MG, Flaherty DC, Hoxha B, Gurji H, Sun J, Hodge LM, Olivencia-Yurvati AH, Mallet RT (2010) Pyruvate-enriched cardioplegia suppresses cardiopulmonary bypass-induced myocardial inflammation. Ann Thorac Surg 90:1529\u20131535. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.06.010","journal-title":"Ann Thorac Surg"},{"key":"3017_CR77","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.resuscitation.2007.04.028","volume":"76","author":"AB Sharma","year":"2008","unstructured":"Sharma AB, Barlow MA, Yang SH, Simpkins JW, Mallet RT (2008) Pyruvate enhances neurological recovery following cardiopulmonary arrest and resuscitation. Resuscitation 76:108\u2013119. https:\/\/doi.org\/10.1016\/j.resuscitation.2007.04.028","journal-title":"Resuscitation"},{"key":"3017_CR78","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1177\/1535370214523703","volume":"239","author":"AQ Nguyen","year":"2014","unstructured":"Nguyen AQ, Cherry BH, Scott GF, Ryou MG, Mallet RT (2014) Erythropoietin: powerful protection of ischemic and post-ischemic brain. Exp Biol Med (Maywood) 239:1461\u20131475. https:\/\/doi.org\/10.1177\/1535370214523703","journal-title":"Exp Biol Med (Maywood)"},{"key":"3017_CR79","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/s0022-4804(03)00148-3","volume":"112","author":"PD Mongan","year":"2003","unstructured":"Mongan PD, Karaian J, Van Der Schuur BM, Via DK, Sharma P (2003) Pyruvate prevents poly-ADP ribose polymerase (PARP) activation, oxidative damage, and pyruvate dehydrogenase deactivation during hemorrhagic shock in swine. J Surg Res 112:180\u2013188. https:\/\/doi.org\/10.1016\/s0022-4804(03)00148-3","journal-title":"J Surg Res"},{"key":"3017_CR80","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.expneurol.2004.01.006","volume":"187","author":"JK Ryu","year":"2004","unstructured":"Ryu JK, Kim SU, McLarnon JG (2004) Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington\u2019s disease. Exp Neurol 187:150\u2013159. https:\/\/doi.org\/10.1016\/j.expneurol.2004.01.006","journal-title":"Exp Neurol"},{"key":"3017_CR81","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neulet.2006.11.058","volume":"413","author":"JH Park","year":"2007","unstructured":"Park JH, Hong YH, Kim HJ, Kim SM, Kim MJ, Park KS, Sung JJ, Lee KW (2007) Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model. Neurosci Lett 413:265\u2013269. https:\/\/doi.org\/10.1016\/j.neulet.2006.11.058","journal-title":"Neurosci Lett"},{"key":"3017_CR82","doi-asserted-by":"publisher","first-page":"RC111","DOI":"10.1523\/JNEUROSCI.20-23-j0001.2000","volume":"20","author":"KM Noh","year":"2000","unstructured":"Noh KM, Koh JY (2000) Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J Neurosci 20:RC111. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-23-j0001.2000","journal-title":"J Neurosci"},{"key":"3017_CR83","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1423-0127-16-63","volume":"16","author":"SS Ahmed","year":"2009","unstructured":"Ahmed SS, Santosh W, Kumar S, Christlet HT (2009) Metabolic profiling of Parkinson\u2019s disease: evidence of biomarker from gene expression analysis and rapid neural network detection. J Biomed Sci 16:63. https:\/\/doi.org\/10.1186\/1423-0127-16-63","journal-title":"J Biomed Sci"},{"key":"3017_CR84","doi-asserted-by":"publisher","first-page":"e146400","DOI":"10.1172\/JCI146400","volume":"132","author":"D Mallet","year":"2022","unstructured":"Mallet D, Dufourd T, Decourt M, Carcenac C, Bossu P et al (2022) A metabolic biomarker predicts Parkinson\u2019s disease at the early stages in patients and animal models. J Clin Invest 132:e146400. https:\/\/doi.org\/10.1172\/JCI146400","journal-title":"J Clin Invest"},{"key":"3017_CR85","doi-asserted-by":"publisher","first-page":"E272","DOI":"10.1152\/ajpendo.1982.243.4.E272","volume":"243","author":"AR Conn","year":"1982","unstructured":"Conn AR, Steele RD (1982) Transport of alpha-keto analogues of amino acids across blood-brain barrier in rats. Am J Physiol 243:E272-277. https:\/\/doi.org\/10.1152\/ajpendo.1982.243.4.E272","journal-title":"Am J Physiol"},{"key":"3017_CR86","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1152\/ajplegacy.1973.224.6.1450","volume":"224","author":"WH Oldendorf","year":"1973","unstructured":"Oldendorf WH (1973) Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Am J Physiol 224:1450\u20131453. https:\/\/doi.org\/10.1152\/ajplegacy.1973.224.6.1450","journal-title":"Am J Physiol"},{"issue":"Pt 2","key":"3017_CR87","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1042\/bj3430281","volume":"343","author":"AP Halestrap","year":"1999","unstructured":"Halestrap AP, Price NT (1999) The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 343(Pt 2):281\u2013299","journal-title":"Biochem J"},{"key":"3017_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.2005.03168.x","volume":"94","author":"K Pierre","year":"2005","unstructured":"Pierre K, Pellerin L (2005) Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem 94:1\u201314. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03168.x","journal-title":"J Neurochem"},{"key":"3017_CR89","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1007\/s00018-013-1539-2","volume":"71","author":"LR Gray","year":"2014","unstructured":"Gray LR, Tompkins SC, Taylor EB (2014) Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci 71:2577\u20132604. https:\/\/doi.org\/10.1007\/s00018-013-1539-2","journal-title":"Cell Mol Life Sci"},{"key":"3017_CR90","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.nbd.2004.12.009","volume":"18","author":"HF Poon","year":"2005","unstructured":"Poon HF, Frasier M, Shreve N, Calabrese V, Wolozin B, Butterfield DA (2005) Mitochondrial associated metabolic proteins are selectively oxidized in A30P \u03b1-synuclein transgenic mice\u2014a model of familial Parkinson\u2019s disease. Neurobiol Dis 18:492\u2013498. https:\/\/doi.org\/10.1016\/j.nbd.2004.12.009","journal-title":"Neurobiol Dis"},{"key":"3017_CR91","doi-asserted-by":"publisher","first-page":"52ra73","DOI":"10.1126\/scitranslmed.3001059","volume":"2","author":"B Zheng","year":"2010","unstructured":"Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS et al (2010) PGC-1\u03b1, a potential therapeutic target for early intervention in Parkinson\u2019s disease. Sci Transl Med 2:52ra73. https:\/\/doi.org\/10.1126\/scitranslmed.3001059","journal-title":"Sci Transl Med"},{"key":"3017_CR92","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bbrc.2017.05.162","volume":"489","author":"Y Miki","year":"2017","unstructured":"Miki Y, Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K (2017) Alteration of mitochondrial protein PDHA1 in Lewy body disease and PARK14. Biochem Biophys Res Commun 489:439\u2013444. https:\/\/doi.org\/10.1016\/j.bbrc.2017.05.162","journal-title":"Biochem Biophys Res Commun"},{"key":"3017_CR93","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/mds.104","volume":"3","author":"AM Smith","year":"2018","unstructured":"Smith AM, Depp C, Ryan BJ, Johnston GI, Alegre-Abarrategui J et al (2018) Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson\u2019s blood cells. Mov Disord 3:1580\u20131590. https:\/\/doi.org\/10.1002\/mds.104","journal-title":"Mov Disord"},{"key":"3017_CR94","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1474-9726.2012.00805.x","volume":"11","author":"PW Stacpoole","year":"2012","unstructured":"Stacpoole PW (2012) The pyruvate dehydrogenase complex as a therapeutic target for age-related diseases. Aging Cell 11:371\u2013377. https:\/\/doi.org\/10.1111\/j.1474-9726.2012.00805.x","journal-title":"Aging Cell"},{"key":"3017_CR95","doi-asserted-by":"publisher","first-page":"368ra174","DOI":"10.1126\/scitranslmed.aag2210","volume":"8","author":"A Ghosh","year":"2016","unstructured":"Ghosh A, Tyson T, George S, Hildebrandt EN, Steiner JA et al (2016) Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson\u2019s disease. Sci Transl Med 8:368ra174. https:\/\/doi.org\/10.1126\/scitranslmed.aag2210","journal-title":"Sci Transl Med"},{"key":"3017_CR96","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1172\/JCI129987","volume":"129","author":"R Cai","year":"2019","unstructured":"Cai R, Zhang Y, Simmering JE, Schultz JL, Li Y et al (2019) Enhancing glycolysis attenuates Parkinson\u2019s disease progression in models and clinical databases. J Clin Invest 129:4539\u20134549. https:\/\/doi.org\/10.1172\/JCI129987","journal-title":"J Clin Invest"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-03017-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-022-03017-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-03017-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T11:36:12Z","timestamp":1664537772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-022-03017-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,3]]},"references-count":96,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["3017"],"URL":"https:\/\/doi.org\/10.1007\/s12035-022-03017-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,3]]},"assertion":[{"value":"25 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal study was pre-reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) and performed under the Guideline for Laboratory Animal Care and Use of the Asan Institute for Life Sciences (Asan Medical Center; Seoul, Korea).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}